These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20738459)

  • 1. Juvenile psoriasis and its clinical management: a European expert group consensus.
    Ståhle M; Atakan N; Boehncke WH; Chimenti S; Daudén E; Giannetti A; Hoeger P; Joly P; Katsambas A; Kragballe K; Lambert J; Ortonne JP; Prinz JC; Puig L; Seyger M; Strohal R; Van De Kerkhoff P; Sterry W
    J Dtsch Dermatol Ges; 2010 Oct; 8(10):812-8. PubMed ID: 20738459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus.
    Boehncke WH; Brasie RA; Barker J; Chimenti S; Daudén E; de Rie M; Dubertret L; Giannetti A; Katsambas A; Kragballe K; Naeyaert JM; Ortonne JP; Peyrí J; Prinz JC; Saurat JH; Strohal R; van de Kerkhof P; Sterry W;
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):988-98. PubMed ID: 16922950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the treatment of nail psoriasis in patients with moderate to severe psoriasis: a dermatology expert group consensus.
    Langley RG; Saurat JH; Reich K;
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):373-81. PubMed ID: 22151734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores.
    de Jager ME; van de Kerkhof PC; de Jong EM; Seyger MM
    Br J Dermatol; 2010 Nov; 163(5):1099-101. PubMed ID: 20716218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology].
    Puig L; Bordas X; Carrascosa JM; Daudén E; Ferrándiz C; Hernanz JM; López-Estebaranz JL; Moreno JC; Sánchez-Carazo JL; Vanaclocha F; Vázquez-Veiga H;
    Actas Dermosifiliogr; 2009 May; 100(4):277-86. PubMed ID: 19463230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis.
    Gulliver W; Lynde C; Dutz JP; Vender RB; Yeung J; Bourcier M; Dion PL; Hong CH; Searles G; Poulin Y
    J Cutan Med Surg; 2015; 19(1):22-7. PubMed ID: 25775659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey.
    Dubertret L; Mrowietz U; Ranki A; van de Kerkhof PC; Chimenti S; Lotti T; Schäfer G;
    Br J Dermatol; 2006 Oct; 155(4):729-36. PubMed ID: 16965422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.
    Krueger G; Koo J; Lebwohl M; Menter A; Stern RS; Rolstad T
    Arch Dermatol; 2001 Mar; 137(3):280-4. PubMed ID: 11255325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
    Daudén E; Puig L; Ferrándiz C; Sánchez-Carazo JL; Hernanz-Hermosa JM;
    J Eur Acad Dermatol Venereol; 2016 Mar; 30 Suppl 2():1-18. PubMed ID: 26812550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuscan consensus on the diagnosis, treatment and follow-up of moderate-to-severe psoriasis.
    Prignano F; Tripo L; Amato L; Bagnoni G; Bartoli L; Battistini S; Bellini M; Brandini L; Caproni M; Cardinali C; Castelli A; Cecchi R; Cervadoro G; Dini V; Fimiani M; Eberle O; Fabbri P; Lo Scocco G; Martini P; Marsili F; Mazzatenta C; Niccoli MC; Peccianti C; Pellegrino M; Romanelli M; Sirna R; Taviti F; Volpi V; Pimpinelli N
    G Ital Dermatol Venereol; 2017 Apr; 152(2):99-108. PubMed ID: 25588061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalp psoriasis: European consensus on grading and treatment algorithm.
    Ortonne J; Chimenti S; Luger T; Puig L; Reid F; Trüeb RM
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1435-44. PubMed ID: 19614856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Findings in children with psoriasis].
    Burgers SA; van Vloten WA
    Ned Tijdschr Geneeskd; 1999 Jan; 143(3):148-51. PubMed ID: 10086130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris.
    Nast A; Kopp IB; Augustin M; Banditt KB; Boehncke WH; Follmann M; Friedrich M; Huber M; Kahl C; Klaus J; Koza J; Kreiselmaier I; Mohr J; Mrowietz U; Ockenfels HM; Orzechowski HD; Prinz J; Reich K; Rosenbach T; Rosumeck S; Schlaeger M; Schmid-Ott G; Sebastian M; Streit V; Weberschock T; Rzany B; ;
    J Dtsch Dermatol Ges; 2007 Jul; 5 Suppl 3():1-119. PubMed ID: 17615051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach.
    Strober B; Berger E; Cather J; Cohen D; Crowley JJ; Gordon KB; Gottlieb A; Horn EJ; Kavanaugh AF; Korman NJ; Krueger GG; Leonardi CL; Menter A; Schwartzman S; Sobell JM; Young M
    J Am Acad Dermatol; 2009 Jul; 61(1 Suppl 1):S1-S46. PubMed ID: 19527820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How patients experience psoriasis: results from a European survey.
    Fouéré S; Adjadj L; Pawin H
    J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():2-6. PubMed ID: 16274404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitiligo on self-reported health-related quality of life.
    Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
    Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases.
    Beattie PE; Lewis-Jones MS
    Br J Dermatol; 2006 Jul; 155(1):145-51. PubMed ID: 16792766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research in practice: the systemic aspects of psoriasis.
    Boehncke WH; Boehncke S
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis: characterization of six different clinical phenotypes.
    Guinot C; Latreille J; Perrussel M; Doss N; Dubertret L;
    Exp Dermatol; 2009 Aug; 18(8):712-9. PubMed ID: 19366373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis.
    Seité S; Paries J; Reygagne P; Hamidou Z; Jouanique C; Perez-Pala G; Rougier A
    J Cosmet Dermatol; 2009 Jun; 8(2):108-13. PubMed ID: 19527334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.